Qatar Airways Cargo transported more than 3mn tonnes of air freight, accounting for 7.99% share in the global market in fiscal 2021/22.
This, the national airline said in its annual report for 2021/22, represents a tonnage growth of 272,975 tonnes in chargeable weight, up 10% on the same period in the previous year.
The report noted Qatar Airways Cargo maintained its position as the world’s leading air cargo carrier throughout the financial year, forging ahead with a strategic focus on growth, sustainability and digitalisation, and supporting the continuity of global trade, despite ongoing market challenges.
Serving over 65 dedicated freighter destinations and more than 140 belly-hold passenger destinations worldwide, the carrier mirrored its strong performance from 2020/2021, operating a maximum of 155 flights per day at its peak in June 2021.
With a significant proportion of this gross tonnage comprising of medical equipment, personal protective equipment (PPE) and critical supplies to support the ongoing global pandemic recovery, the carrier also further cemented its status as a major transporter of pharmaceuticals and medical supplies.
The airline transported more than 600mn doses of Covid-19 vaccines over the course of the pandemic to date and also concentrated its efforts in enhancing its renowned pharma product and industry presence, while also ensuring commitment to its ground-breaking ‘WeQare’ initiative, which is based on the core pillars of sustainability: environment, society, economy and culture.
In July 2021, Qatar Airways Cargo became a member of both Pharma.Aero as well as the Cool Chain Association, in its endeavour to collaborate in defining the highest standards in the shipment of valuable pharma goods and ensuring sustainability in transportation by avoiding integrity deviations leading to medical or food wastage.
Qatar Airways Cargo was able to fulfil its commitment to the Unicef Covax programme, transporting over 154mn doses of Covid-19 vaccines as part of a memorandum of understanding signed in February 2021, providing five years of vaccine transport support to this important cause.